Diabetic Polyneuropathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2024-12-23
FDA Approved: PREGABALIN — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for pregabalin filed by Chartwell RX, LLC (ANDA212865).